Comparing Risk and Design Between Oxygen Concentrators and Invasive Blood Pressure Monitors

03 Apr 2026

How Intended Use, Essential Performance, and Clinical Environment Shape Very Different Compliance Strategies under IEC 60601

Medical devices can look similar from a regulatory distance, yet differ dramatically once intended use, environment, and patient interaction are considered. Oxygen concentrators and invasive blood pressure (IBP) monitors are a clear example of this divergence. Both fall under the IEC 60601 family of standards, but their risk profiles, performance expectations, and testing strategies are shaped by fundamentally different clinical realities.

Different Devices, Different Risks

Oxygen concentrators are non-invasive devices that extract oxygen from ambient air and deliver it to patients through a nasal cannula or mask. They are often used in home or non-professional environments and may be operated by patients themselves or by caregivers with limited training.

Invasive blood pressure monitors, by contrast, are used in critical care settings and rely on catheters inserted directly into a patient’s arterial system to continuously measure blood pressure waveforms. The invasive nature of these systems places them in a higher risk category, with tighter safety margins and more stringent regulatory expectations.

In addition, invasive monitoring often involves Type CF (cardiac floating) applied parts, which carry stricter requirements for electrical isolation and leakage current control under IEC 60601-1 than most non-invasive respiratory devices.

Applying the IEC 60601 Framework

IEC 60601-1 provides the baseline requirements for electrical, mechanical, and thermal safety, but it is only the starting point for complex devices. Oxygen concentrators are primarily evaluated under ISO 80601-2-69, while invasive blood pressure monitors fall under IEC 60601-2-34. These particular standards introduce device-specific requirements that can modify or override portions of the base standard. In practice, this means manufacturers must identify applicable particular and collateral standards early, as applying them late in development often results in additional testing or design changes.

For home-use oxygen concentrators, IEC 60601-1-11 also becomes a key consideration, introducing requirements tied to the unique risks of the home healthcare environment.

It’s always recommended to work with an experienced consultant if unsure of the applicable particular or collateral standard(s) early in the design process. Choosing the wrong standard, or missing a standard completely, can create unnecessary delays and additional expenses in potential redesign.

Essential Performance as a Regulatory Anchor

Essential performance plays a central role in how both devices are evaluated. For oxygen concentrators, this typically includes parameters such as oxygen concentration and flow delivery. For invasive blood pressure monitors, essential performance is heavily focused on measurement accuracy and signal integrity. Regulators increasingly expect manufacturers to clearly declare essential performance upfront, as it defines what must be maintained under normal operation and single fault conditions. Devices that lack a clearly defined essential performance often face delays or regulatory questions during evaluation.

Environment, Usability, and Human Factors

The intended use environment significantly influences risk management and testing strategy. Oxygen concentrators must account for home healthcare risks, including varied user capabilities, cleaning practices, pets, children, and household electrical conditions.

Invasive blood pressure monitors, while used by trained clinicians, must address risks associated with invasive patient connections and continuous monitoring in high-acuity environments. Because IBP systems rely on an invasive patient interface, manufacturers must also consider additional expectations around biocompatibility, sterility, and infection control that extend beyond core electrical safety testing.

In both cases, usability and human factors are critical, ensuring that devices can be used safely and effectively by their intended users under realistic conditions.

Fault Conditions, Alarms, and EMC

Single fault condition testing is a key component of IEC 60601 compliance and demonstrates how a device behaves when a foreseeable fault occurs, such as a blocked oxygen flow or a disconnected pressure transducer. Alarm systems, governed by IEC 60601-1-8, must clearly communicate priority and meaning, whether alerting a clinician in an ICU or a caregiver in a home setting. Electromagnetic compatibility (EMC) adds another layer of complexity, as both home and clinical environments present increasing levels of electrical noise and wireless interference that devices must tolerate without compromising safety or performance.

As both device types increasingly incorporate software-driven controls and connectivity, manufacturers must also account for cybersecurity risk management, software lifecycle controls, and wireless coexistence considerations as part of overall safety framework.

Designing for Compliance from the Start

Taken together, oxygen concentrators and invasive blood pressure monitors highlight a broader lesson in medical device development: compliance cannot be bolted on at the end. Standards define not just test requirements, but design expectations tied to risk, environment, and clinical use.

Manufacturers that treat regulatory standards as early design inputs rather than downstream checklists are better positioned to reduce rework, manage risk effectively, and bring safe, reliable devices to market with greater confidence. The earlier these differences are mapped into design inputs and test planning, the fewer surprises appear during certification and regulatory review.